Analysis of Immune Response In Bacterial Infection of Obese Subject (NCT02882568) | Clinical Trial Compass
CompletedNot Applicable
Analysis of Immune Response In Bacterial Infection of Obese Subject
France15 participantsStarted 2014-08
Plain-language summary
Improve knowledge of the immune response to sepsis in obese patients. Define immunological and genetic prognostic factors of severe infections which can motivate a change in the therapeutic attitude
Who can participate
Age range18 Years – 80 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* between18 and 80 years
* obesity: BMI \> 30
* presumed bacterial infection:
* pneumonitis (documented or probably)
* pyelonephritis / acute prostatitis
* soft tissue / skin infection (except for bedsore)
* cholecystitis / angiocholitis
* meningitis
* clostridium colitis
* surgical site infection
* signed consent
Exclusion Criteria:
* patients with viral, parasitic or mycotic documented infection
* patients with bacterial infection with treatment\> 4 weeks (ex. endocarditis; osteo- articular infections)
* patients with prior antibiotic treatment (\< 14 days)
* intensive care unit patients
* patients with a history of cancer or malignant hematological disease within the 5 previous years that is currently clinically significant (non metastatic prostatic and basocellular malignancy are excluded)
* patients with systemic disease
* Known diagnosis of human immunodeficiency infection (DICV, HIV…)
* immunosuppression treatment during last month including corticotherapy
* pregnancy
* 3 months follow up not possible
* non signed consent
What they're measuring
1
Patterns of inflammatory and immunological markers in obese patients in sepsis and post- sepsis ("normal") situation